Difficult to get a decent lick by all accounts, couple of brokers appear to have got small allocations to hand out and alto has kept book very tight at its end.
Shell holders and note holders only concern register wise.
Should go well, has a good story and will be regular news flow but I think Altos osteopore ipos the pick of the 2
